Skip to main content
PMC home page
Journal of Epidemiology and Community Health logoLink to Journal of Epidemiology and Community Health
. 2002 Jun;56(6):424–429. doi: 10.1136/jech.56.6.424

Lung cancer: district active treatment rates affect survival

M Cartman 1, A Hatfield 1, M Muers 1, M Peake 1, R Haward 1, D Forman 1
PMCID: PMC1732161  PMID: 12011196

Abstract

Design: A retrospective study of population based data held by the Northern & Yorkshire Cancer Registry and Information Service (NYCRIS), comparing active treatment rates for lung cancer with survival by districts.

Setting: The then 17 districts in Yorkshire and South Humber, England.

Patients: 22 654 patients registered with lung cancer between 1986 and 1994 and followed up until end of 1996.

Results: The overall rates of active treatment (surgery, radiotherapy, and chemotherapy) varied between districts from 37% to 56%. One year survival (with 95% CI) was significantly better in the districts with highest rates of active treatment 23% (22% to 24%) compared with 19% (17% to 20%) for those with lowest treatment rates. Non-small cell lung cancer patients (55%) in the districts with highest active treatment rates had an age adjusted relative risk of death during the follow up period, relative to risk of death in the districts with the lower treatment rates of 0.88 (0.83 to 0.92). Clinically diagnosed patients (34%) had an age adjusted RR of 0.92 (0.86 to 0.96). RR in small cell cancer (11%) was not significant.

Conclusion: This study has shown wide variations in the rates of active treatment for lung cancer patients within districts across one large region of England. Active treatment was strongly associated with improved survival, especially in non-small cell lung cancer.

Full Text

The Full Text of this article is available as a PDF (112.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Connolly C. K., Crawford S. M., Rider P. L., Smith A. D., Johnston C. F., Muers M. F. Carcinoma of the bronchus in the Yorkshire region of England 1976-1990: trends since 1984. Eur Respir J. 1997 Feb;10(2):397–403. doi: 10.1183/09031936.97.10020397. [DOI] [PubMed] [Google Scholar]
  2. Connolly C. K., Jones W. G., Thorogood J., Head C., Muers M. F. Investigation, treatment and prognosis of bronchial carcinoma in the Yorkshire Region of England 1976-1983. Br J Cancer. 1990 Apr;61(4):579–583. doi: 10.1038/bjc.1990.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Davey P. Brain metastases. Curr Probl Cancer. 1999 Mar-Apr;23(2):59–98. doi: 10.1016/s0147-0272(99)90007-7. [DOI] [PubMed] [Google Scholar]
  4. Faggiano F., Partanen T., Kogevinas M., Boffetta P. Socioeconomic differences in cancer incidence and mortality. IARC Sci Publ. 1997;(138):65–176. [PubMed] [Google Scholar]
  5. Fergusson R. J., Gregor A., Dodds R., Kerr G. Management of lung cancer in South East Scotland. Thorax. 1996 Jun;51(6):569–574. doi: 10.1136/thx.51.6.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fry W. A., Phillips J. L., Menck H. R. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer. 1999 Nov 1;86(9):1867–1876. doi: 10.1002/(sici)1097-0142(19991101)86:9<1867::aid-cncr31>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  7. Gregor A., Thomson C. S., Brewster D. H., Stroner P. L., Davidson J., Fergusson R. J., Milroy R., Scottish Cancer Trials Lung Group. Scottish Cancer Therapy Network Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study. Thorax. 2001 Mar;56(3):212–217. doi: 10.1136/thorax.56.3.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hoffman P. C., Mauer A. M., Vokes E. E. Lung cancer. Lancet. 2000 Feb 5;355(9202):479–485. doi: 10.1016/S0140-6736(00)82038-3. [DOI] [PubMed] [Google Scholar]
  9. Langendijk J. A., ten Velde G. P., Aaronson N. K., de Jong J. M., Muller M. J., Wouters E. F. Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys. 2000 Apr 1;47(1):149–155. doi: 10.1016/s0360-3016(99)00540-4. [DOI] [PubMed] [Google Scholar]
  10. Melling P. P., Hatfield A. C., Muers M. F., Peake M. D., Storer C. J., Round C. E., Haward R. A., Crawford S. M. Lung cancer referral patterns in the former Yorkshire region of the UK. Br J Cancer. 2002 Jan 7;86(1):36–42. doi: 10.1038/sj.bjc.6600029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pollock A. M., Vickers N. Breast, lung and colorectal cancer incidence and survival in South Thames Region, 1987-1992: the effect of social deprivation. J Public Health Med. 1997 Sep;19(3):288–294. doi: 10.1093/oxfordjournals.pubmed.a024632. [DOI] [PubMed] [Google Scholar]
  12. Roszkowski K., Pluzanska A., Krzakowski M., Smith A. P., Saigi E., Aasebo U., Parisi A., Pham Tran N., Olivares R., Berille J. A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC). Lung Cancer. 2000 Mar;27(3):145–157. doi: 10.1016/s0169-5002(00)00094-5. [DOI] [PubMed] [Google Scholar]
  13. Schrijvers C. T., Coebergh J. W., van der Heijden L. H., Mackenbach J. P. Socioeconomic variation in cancer survival in the southeastern Netherlands, 1980-1989. Cancer. 1995 Jun 15;75(12):2946–2953. doi: 10.1002/1097-0142(19950615)75:12<2946::aid-cncr2820751223>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  14. Schroen A. T., Detterbeck F. C., Crawford R., Rivera M. P., Socinski M. A. Beliefs among pulmonologists and thoracic surgeons in the therapeutic approach to non-small cell lung cancer. Chest. 2000 Jul;118(1):129–137. doi: 10.1378/chest.118.1.129. [DOI] [PubMed] [Google Scholar]
  15. Silvestri G., Pritchard R., Welch H. G. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. BMJ. 1998 Sep 19;317(7161):771–775. doi: 10.1136/bmj.317.7161.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Watkin S. W., Hayhurst G. K., Green J. A. Time trends in the outcome of lung cancer management: a study of 9,090 cases diagnosed in the Mersey Region, 1974-86. Br J Cancer. 1990 Apr;61(4):590–596. doi: 10.1038/bjc.1990.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Yung R. C., Orens J. B. Radicalism in therapy of lung cancer. Lancet. 2001 Apr 28;357(9265):1306–1307. doi: 10.1016/S0140-6736(00)04526-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Epidemiology and Community Health are provided here courtesy of BMJ Publishing Group

RESOURCES